https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Suppression of SHIP2 contributes to tumorigenesis and proliferation of gastric cancer cells via activation of Akt https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23968 Thu 17 Mar 2022 14:35:49 AEDT ]]> Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:12373 Sat 24 Mar 2018 10:34:55 AEDT ]]> Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27610 Helicobacter pylori infection remains a mainstay of therapy in patients with dyspepsia and this infection. Locally acting drugs such as linaclotide have been an advance in treating the symptoms of constipation-predominant IBS, but do not alter the natural history of the disease. A role for a holistic approach to patients with FGIDs is warranted, as brain-to-gut and gut-to-brain pathways appear to be activated.]]> Sat 24 Mar 2018 07:39:41 AEDT ]]>